Andrew Lane

28PUBLICATIONS
184CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Nov 06, 2026
A living enzymatic adenosine switch couples metabolic rescue to IL-12-driven antitumor immunity.

|Sep 02, 2026
Therapy-Persistent Leukemia Is Selectively Vulnerable to SLC23A1 Restoration via Targeting KHSRP.

|Jul 07, 2026
Tagraxofusp, azacitidine, and venetoclax for blastic plasmacytoid dendritic cell neoplasm.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|Apr 20, 2026
The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.

|Mar 19, 2026
Live-cell Pick-Seq (LiP-Seq): Interrogating ultra-rare mantle cell lymphoma persistent cells after CART19 therapy.

Ran Xu, Gongwei Wu, Siobhan Rice

Pageof 5

Frequent Collaborators

8 joint publications

Naveen Pemmaraju

5 joint publications

Qingyu Luo

5 joint publications

Daniel J DeAngelo

5 joint publications

Marina Konopleva